7 June 2015 marked the start of a joint European project in Halle intended to shed light on common molecular features in the early development of neurodegenerative diseases. Five partner institutions from Halle, Leipzig, Erlangen, Paris (France) and Oslo (Norway) have set themselves the goal of working on therapeutic strategies based on new findings. The project, which is set to run over a three-year period, has been awarded a total of 1.7 million euros in funding from the European Union.
Besides the devastating effects they have on patients, neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's diseases have one key thing in common: their pathology is based on the aggregation and accumulation of misfolded proteins in the brain.
This results in a loss of tissue and function and, consequently, severe neurological disorders which are fatal in the advanced stages of the diseases. Until now, the mechanisms associated with the early development of these diseases have mainly been researched independently of each other.
Latest investigations, however, have suggested similarities in the molecular development processes of the diseases. This is centered around the hypothesis that misfolded peptides, which frequently arise in the case of such diseases, also induce a deposit of other proteins.
This means that a peptide triggers degenerative processes which become more intense through the coaggregation of peptides. The main target proteins to be investigated include Abeta, alpha-synuclein and huntingtin.
Fraunhofer IZI's Molecular Drug Biochemistry and Therapy Development (MWT) project group is coordinating the EU project and aims to research these common features and develop new therapeutic strategies.
Led by Professor Hans-Ulrich Demuth and Dr Stephan Schilling, the group will contribute their many years of experience researching misfolded proteins to the project. Consequently, the Halle scientists have set themselves the chief task of synthesizing respective proteins and antibodies for their subsequent investigation. At Leipzig University, detailed investigations into the development of Alzheimer's will then be carried out building on this research.
At the Friedrich-Alexander University Erlangen-Nürnberg, the focus is placed on research into Huntington's disease, while the French National Institute of Health and Medical Research in Paris will look at the development of Parkinson's disease with an eye to the aspects mentioned above. At the University of Oslo, a computer-based database will be created, which will draw on the histological data generated by the units in order to gain a corresponding, local correlation between protein deposits in the brain for each different disease model.
Information on funding
This project is being funded by the "EU Joint Programme – Neurodegenerative Disease Research (JPND)", the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase the coordinated investments of its partner countries and thus to support research which looks to identify causes of disease, therapy development and suitable care measures for patients. Further information can be found at: www.jpnd.eu
Presse Institute | Fraunhofer-Gesellschaft
Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy